Arkolith/Insider Trading/BLTE/Form 4

Mata Nathan L.

Chief Scientific OfficerBELITE BIO, INC (BLTE) · full profile →Form 4 · filed May 6, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$156K
Net Open-Market Flow
-$156K
Transactions
6
6 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 5, 2026Sell(S)120$153.92$18K3K
May 5, 2026Sell(S)363$154.44$56K2K
May 5, 2026Sell(S)173$155.48$27K2K
May 5, 2026Sell(S)121$156.53$19K2K
May 5, 2026Sell(S)155$157.29$24K2K
May 5, 2026Sell(S)68$158.11$11K2K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-209004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML